StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy and safety of StrataXRT® in comparison to
standard of care (defined using the Common Terminology Criteria for Adverse Events [CTCAE],
version 5.0) by assessing the severity of inguinal RD in patients receiving elective
radiation therapy +/- systemic therapy to the bilateral inguinal nodes.